Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
dc.contributor.author | Dockery, Lance | |
dc.contributor.author | Daniel, Marie-Christine | |
dc.date.accessioned | 2023-08-30T14:50:58Z | |
dc.date.available | 2023-08-30T14:50:58Z | |
dc.date.issued | 2023-08-09 | |
dc.description.abstract | Dendronized nanoparticles, also called nanoparticle-cored dendrimers, combine the advantages of nanoparticles and dendrimers. These very stable and polyvalent nanoparticles can be used for diverse applications. One such application is drug delivery, because the dendrons can enhance the density of the payload. In this report, we describe the design of multifunctional gold nanoparticles (AuNPs) coated with poly(propylene imine) (PPI) dendrons that contain both prostate cancer active targeting and chemotherapeutic drugs. The PPI dendron is a good candidate for the design of drug delivery vehicles because of its ability to induce a proton sponge effect that will enhance lysosomal escape and intracellular therapeutic delivery. The chemotherapeutic drug used is doxorubicin (DOX), and it was linked to the dendron through a hydrazone acid-sensitive bond. Subsequent acidification of the AuNP system to a pH of 4–5 resulted in the release of 140 DOX drugs per nanoparticles. In addition, the PPI dendron was conjugated via “click” chemistry to an EphA2-targeting antibody fragment that has been shown to target prostate cancer cells. In vitro cell viability assays revealed an IC50 of 0.9 nM for the targeted DOX-bearing AuNPs after 48 h incubation with PC3 cells. These results are very promising upon optimization of the system. | en_US |
dc.description.sponsorship | This research was funded by the NSF (CBET-1705538). L.T.D. was also supported by the NIH (TT32GM066706-19). The APC was funded by the University of Maryland, Baltimore County (PRFEXC02). The authors thank John Strong (Electron Microscopy Core Imaging Facility (EMCIF), University of Maryland, Baltimore) for the TEM imaging of the PC3 cells. This work utilized an EM sample preparation instrument that was purchased with funding from a National Institutes of Health SIG grant (1S10RR26870-1) awarded to the University of Maryland Baltimore. The authors are also grateful to Charles Bieberich’s group for providing the PC3 cells as well as for training L.T.D. for the in vitro assays. | en_US |
dc.description.uri | https://www.mdpi.com/1999-4923/15/8/2103 | en_US |
dc.format.extent | 14 pages | en_US |
dc.genre | journal articles | en_US |
dc.identifier | doi:10.13016/m2g2gx-51c5 | |
dc.identifier.citation | Dockery, Lance T., and Marie-Christine Daniel. 2023. "Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles" Pharmaceutics 15, no. 8: 2103. https://doi.org/10.3390/pharmaceutics15082103 | en_US |
dc.identifier.uri | https://doi.org/10.3390/pharmaceutics15082103 | |
dc.identifier.uri | http://hdl.handle.net/11603/29434 | |
dc.language.iso | en_US | en_US |
dc.publisher | MDPI | en_US |
dc.relation.isAvailableAt | The University of Maryland, Baltimore County (UMBC) | |
dc.relation.ispartof | UMBC Chemistry & Biochemistry Department Collection | |
dc.relation.ispartof | UMBC Faculty Collection | |
dc.relation.ispartof | UMBC Student Collection | |
dc.rights | This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author. | en_US |
dc.rights | Attribution 4.0 International (CC BY 4.0) | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles | en_US |
dc.type | Text | en_US |
dcterms.creator | https://orcid.org/0000-0002-1964-4135 | en_US |
dcterms.creator | https://orcid.org/0000-0002-7336-5655 | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.56 KB
- Format:
- Item-specific license agreed upon to submission
- Description: